ESC TV Today – Your Cardiovascular News

European Society of Cardiology
undefined
Nov 20, 2024 • 23min

Season 3 - Ep.5: Aortic aneurysms - Return to elite sports after a severe cardiac event

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Aortic aneurysms Return to elite sports after a severe cardiac event Milestones: CAST Host: Emer Joyce Guests: Carlos Aguiar, Jose Rodriguez Palomares, Harald Jorstad Want to watch that episode? Go to: https://esc365.escardio.org/event/1795 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Emer Joyce, Nicolle Kraenkel and Jose Rodriguez Palomares have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi Aventis, Novo Nordisk, Terumo. Harald Jorstad has declared to have potential conflicts of interest to report: unrestricted research grants to institution: Dutch Olympic Committee, Dutch Heart Foundation, Zon-Mw, Heart to Handle. Unrestricted, unrelated research grants to institution: Novartis, Amarin, Novo Nordisk, Sanofi. Unrelated advisory fees to institution: Amarin, Amgen. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
undefined
Nov 7, 2024 • 25min

Season 3 - Ep.4: Heart disease in dialysis patients - Substance abuse and heart disease

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Heart disease in dialysis patients Substance abuse and heart disease Snapshots: Pneumopericardium Host: Emer Joyce Guests: Carlos Aguiar, Patrick Mark, Theo Pezel, Stephan Achenbach Want to watch that episode? Go to: https://esc365.escardio.org/event/1794 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Emer Joyce, Nicolle Kraenkel and Theo Pezel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi Aventis, Novo Nordisk, Terumo. Patrick Mark has declared to have potential conflicts of interest to report: lecture/advisory board honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Pharmacosmos, Astellas, GSK, Vifor. Grants from Boehringer Ingelheim, AstraZeneca. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
undefined
5 snips
Oct 24, 2024 • 14min

Season 3 - Ep.3: Extended interview on the new 2024 ESC Guidelines on chronic coronary syndromes

Christiaan Vrints, a cardiologist from Antwerp University Hospital, shares valuable insights on the 2024 ESC guidelines regarding chronic coronary syndromes. He discusses the differences between traditional coronary artery issues and microcirculation disturbances. The conversation dives into diagnostic techniques, highlighting coronary CT angiography's role for low to moderate-risk patients. Vrints emphasizes the importance of understanding non-obstructive conditions, gender disparities in diagnoses, and personalized treatment options for conditions like coronary vasospasm.
undefined
6 snips
Oct 24, 2024 • 24min

Season 3 - Ep.3: Optimal management of angina - Artificial sweeteners and cardiovascular risk

Join experts Carlos Aguiar, a cardiology specialist, Christiaan Vrints from Antwerp University Hospital, and Marco Witkowski of Charité University, as they unpack critical insights on angina management. They discuss the latest ESC guidelines for chronic coronary syndromes and the importance of personalized treatment strategies. The conversation also delves into the cardiovascular risks associated with artificial sweeteners like erythritol, emphasizing the need for caution in using these alternatives, especially in vulnerable populations.
undefined
Oct 10, 2024 • 23min

Season 3 - Ep.2: The why and how of MRAs in Heart Failure - Managing electrical storm

In this engaging discussion, guests Carlos Aguiar, a leading cardiology expert, Sana Al-Khatib from Duke University, and Rudolf de Boer from Erasmus University dive into the intricacies of heart failure treatment. They clarify which mineralocorticoid receptor antagonists (MRAs) suit different heart failure patients. Sana tackles the complex management of electrical storms, while Rudolf sheds light on the use of aldosterone antagonists. The group also debunks myths, like garlic's role in heart health, ensuring listeners stay well-informed on vital cardiovascular topics.
undefined
Sep 26, 2024 • 22min

Season 3 - Ep.1: Strategic decisions in afib - Critical evaluation of clinical trials

Stephan Achenbach, a leading cardiology expert, joins Carlos Aguiar, a top atrial fibrillation researcher, Jane Armitage, a clinician renowned for her work on clinical trials, and Isabel Deisenhofer, an authority on cardiovascular study evaluation. They dive into strategic decisions in managing atrial fibrillation, discussing new guidelines that emphasize rhythm control and catheter ablation. The group also explores the importance of designing reliable clinical trials and the need for patient involvement in advanced cardiac treatment decisions.
undefined
Aug 15, 2024 • 21min

Season 2 - Ep. 22: Lipid-lowering therapy beyond statins - Management of cardiac fibroelastoma

Join experts Stephan Achenbach, a leading cardiology figure, Carlos Aguiar, lipid management authority, Kyle Klarich, cardiac specialist, and Konstantinos Koskinas, renowned researcher, as they dive into innovative strategies for managing cardiac fibroelastomas and advancing lipid therapy beyond statins. They discuss the latest research highlighting new therapeutic options, evaluate the effectiveness and side effects of current treatments, and examine the importance of LDL cholesterol reduction in cardiovascular health. A must-listen for those in the field!
undefined
5 snips
Aug 1, 2024 • 26min

Season 2 - Ep.21: Drug treatment of HCM - Humour in medicine

Join leading cardiology experts Carlos Aguiar and Milind Desai, alongside the witty Rohin Francis, as they delve into the latest advancements in drug treatments for hypertrophic cardiomyopathy. They discuss innovative therapies, including cardiac myosin inhibitors, and evaluate their efficacy and safety. The trio also highlights the healing power of humor in medicine, sharing how laughter can enhance patient communication and reduce anxiety. Plus, dive into the fundamentals of regression analysis in medical research for a comprehensive and entertaining experience!
undefined
4 snips
Jul 18, 2024 • 24min

Season 2 - Ep.20: Lifetime management of aortic valve stenosis - Spirituality and cardiovascular health

Cardiologist Carlos Aguiar, spirituality expert Kavitha Chinnaiyan, and renowned cardiologist Francesco Maisano discuss lifetime management of aortic valve stenosis and the impact of spirituality on cardiovascular health. Topics include personalized therapy options, integrating spirituality in patient care, and the use of AI technology for statistical analyses in medicine.
undefined
Jul 4, 2024 • 23min

Season 2 - Ep.19: Coronary artery calcium scoring - Checklists in aviation and in medicine

Experts Thomas Achenbach, Carlos Aguiar, Michael Blaha, and Edward Nicol discuss coronary artery calcium scoring and the importance of checklists in medicine and aviation. They also explore how being married reduces cardiovascular mortality, emphasizing teamwork and communication in healthcare.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app